Association between Omentin Levels and Insulin Resistance in Pregnancy

Abstract

Aims:

Omentin is a new adipokine secreted mainly from visceral adipose tissue. Serum omentin is found to be reduced in patients with impaired glucose tolerance, type 2 diabetes mellitus, obesity and insulin resistant states. Despite the fact that pregnancy is also characterized with hyperinsulinemia, literature is lacking about data of omentin levels and its association with insulin resistance in pregnant women. We aimed to evaluate the association of omentin levels and insulin resistance in pregnant women and to compare these levels with those of non-pregnant, non-diabetic women.

Methods:

Uncomplicated pregnant women who admit to our outpatient clinics for routine follow-up were included in the study group. Non-pregnant women without diabetes mellitus were served as control group. Fasting glucose, insulin, omentin levels and HOMA IR were recorded. SPSS 15.0 for Windows was used for statistical analysis.

Results:

There were 36 pregnant women in the study group and 37 healthy, non-pregnant women in the control group. Serum omentin and fasting glucose levels were significantly decreased and fasting insulin was significantly increased in the study group compared to control group.

Conclusion:

Omentin might be an indicator of insulin resistance in pregnant women. Larger prospective studies are needed to claim whether omentin can have a clinical use for diagnosis of gestational diabetes mellitus.

Key words

omentin - insulin resistance - pregnancy

• References

• 1 Schaffler A, Neumeier A, Herfarth H et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta 2005; 1732: 96-102
• 2 Yang RZ, Lee MJ, Hu H et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006; 290: E1253-E1261
• 3 Tan BK, Adya R, Randeva HS. Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease. Trends Cardiovasc Med 2010; 20: 143-148
• 4 Cai RC, Wei L, Di JZ et al. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua yi xue za zhi 2009; 89: 381-384
• 5 Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice 2010; 88: 29-33
• 6 de Souza Batista CM, Yang RZ, Lee MJ et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56: 1655-1661
• 7 Dandona P, Aljada A, Chaudhuri A et al. Metabolic syndrome – A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005; 111: 1448-1454
• 8 Senolt L, Polanska M, Filkova M et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1410-1411
• 9 Knopp RH, Montes A, Warth MR. Carbohydrate and lipid metabolism. Laboratory Indices of Nutritional Status in Pregnancy. Washington, D.C: National Academy of Sciences; 1978: 35-88
• 10 Freinkel N, Phelps RL, Metzger BE. Intermediary metabolism during normal pregnancy. In: Sutherland HW, Stowers JM. (ed.). Carbohydrate Metabolism in Pregnancy and the Newborn. New York: Springer-Verlag; 1979: 1-31
• 11 Burt RL, Davidson IW. Insulin half-life and utilization in normal pregnancy. Obstet Gynecol 1974; 43: 161-170
• 12 Berson SA, Yalow RS. Insulin “antagonists” and insulin resistance. In: Ellenberg M, Rifkin H. (ed.). Diabetes Mellitus: Theory and Practice. New York: McGraw-Hill; 1970: 388-423
• 13 Orlik B, Madej P, Owczarek A et al. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol 2013 doi: 10.1111/cen.12381. [Epub ahead of print]
• 14 Tan BK, Adya R, Farhatullah S et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008; 57: 801-808
• 15 Moreno-Navarrete JM, Catalan V, Ortega F et al. Circulating omentin concentration increases after weight loss. Nutr Metab 2010; 7
• 16 Tan BK, Adya R, Farhatullah S et al. Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome. Diabetes 2010; 59: 3023-3031
• 17 Alcelik A, Tosun M, Ozlu MF et al. Serum Levels of Omentin in End-Stage Renal Disease Patients. Kidney Blood Press R 2012; 35: 511-516
• 18 Tan BK, Pua S, Syed F et al. Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diab Med 2008; 25: 1254-1255
• 19 Yan P, Liu D, Long M et al. Changes of Serum Omentin Levels and Relationship between Omentin and Adiponectin Concentrations in Type 2 Diabetes Mellitus. Exp Clin Endocr Diab 2011; 119: 257-263
• 20 Lewandowski K, Nadel I, Lewinski A et al. Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol 2010; 81: 907-912
• 21 Nielsen LR, Ekbom P, Damm P et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004; 27: 1200-1201